AFWM
IOVA icon

Abich Financial Wealth Management’s Iovance Biotherapeutics IOVA Stock Holding History

Abich Financial Wealth Management’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$8.15K Buy
868
+648
+295% +$6.14K 0.02% 213
2024
Q2 		$1.76K Buy
220
+202
+1,122% +$2.17K ﹤0.01% 507
2024
Q1 		$267 Buy
+18
New +$210 ﹤0.01% 464

Other funds holding IOVA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
MFM
MHR Fund Management New York $1.37B AUM 68.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Abich Financial Wealth Management's IOVA Position: Q3 2024 in Review

Abich Financial Wealth Management increased its Iovance Biotherapeutics (IOVA) stake by 295% in Q3 2024, buying an estimated $6.14K and bringing the position to 868 shares worth $8.15K. The position accounts for 0.02% of the portfolio, ranked #213.

Abich Financial Wealth Management first reported a position in IOVA in Q1 2024 and has held it in 3 quarters since. 286 funds tracked by Wall St. Rank hold IOVA as of Q3 2024.

  • Abich Financial Wealth Management held 868 shares of Iovance Biotherapeutics worth $8.15K as of Q3 2024.
  • Abich Financial Wealth Management bought 648 Iovance Biotherapeutics shares in Q3 2024, an estimated $6.14K.
  • Iovance Biotherapeutics made up 0.02% of Abich Financial Wealth Management's portfolio in Q3 2024, its #213 holding.
  • Abich Financial Wealth Management first reported a position in Iovance Biotherapeutics in Q1 2024 and has held it in 3 quarters since.
  • 286 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q3 2024.

Based on Abich Financial Wealth Management's 13F filing for Q3 2024, filed 25 Oct 2024.